RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 59 filers reported holding RA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,793,000 | -45.4% | 303,258 | -55.7% | 0.01% | -50.0% |
| Q4 2018 | $12,449,000 | +22.6% | 683,995 | +21.8% | 0.01% | +233.3% |
| Q3 2018 | $10,158,000 | +1316.7% | 561,522 | +679.4% | 0.00% | – |
| Q2 2018 | $717,000 | +197.5% | 72,041 | +58.5% | 0.00% | – |
| Q1 2018 | $241,000 | -3.2% | 45,441 | +55.1% | 0.00% | – |
| Q4 2017 | $249,000 | -45.5% | 29,294 | -6.3% | 0.00% | – |
| Q3 2017 | $457,000 | -22.0% | 31,271 | 0.0% | 0.00% | – |
| Q2 2017 | $586,000 | +250.9% | 31,271 | +299.0% | 0.00% | – |
| Q1 2017 | $167,000 | +178.3% | 7,837 | +97.0% | 0.00% | – |
| Q4 2016 | $60,000 | – | 3,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $288,094,000 | 13.62% |
| RA Capital Management | 4,858,260 | $227,998,000 | 6.91% |
| HAVENS ADVISORS LLC | 116,000 | $5,444,000 | 4.77% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,115,600 | $99,286,000 | 3.16% |
| SYQUANT CAPITAL SAS | 129,690 | $6,086,000 | 3.13% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 391,758 | $18,386,000 | 3.02% |
| Kellner Capital, LLC | 91,100 | $4,275,000 | 2.71% |
| Telemetry Investments, L.L.C. | 17,100 | $803,000 | 2.68% |
| Versor Investments LP | 1,002,649 | $47,054,000 | 2.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,519,718 | $71,320,000 | 2.28% |